Inactive Instrument

Other languages MAXO CAP

Equities

Maxpro Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01
Apollomics, Inc. completed the acquisition of Maxpro Capital Acquisition Corp. from MP One Investment LLC and others in a reverse merger.	29/23/29
Apollomics Gets Orphan Drug Designation for Vebreltinib to Treat Lung Cancer	15/22/15
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/22/03
Apollomics to be Listed on Nasdaq Through Business Combination With Maxpro Capital Acquisition	14/22/14
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11
Maxpro Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/22/17

No results for this search